Loading chat...
DE HB329
Bill
Status
4/17/2020
Primary Sponsor
Sean Lynn
Click for details
AI Summary
-
Prohibits life, disability, and long-term care insurance companies from denying, refusing to issue or renew, canceling, or restricting coverage solely because an individual has been prescribed pre-exposure prophylaxis (PrEP) medication to prevent HIV infection
-
Bars insurers from adding surcharges or rating factors to premiums based solely on an individual's use of PrEP medication
-
Prevents insurers from discriminating in policy offerings, pricing, claims payment, or any other policy conditions based on PrEP use without additional actuarial justification
-
PrEP medication reduces the risk of HIV transmission by up to 99% when taken daily and is used by individuals at high risk of contracting HIV
Legislative Description
An Act To Amend Title 18 Of The Delaware Code Relating To Insurance Discrimination Based On Pre-exposure Prophylaxis Medication To Prevent Hiv Infection.
Last Action
Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House
4/17/2020